GHK-Cu vs Copper Peptide AHK-Cu
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Copper Peptide, Glycyl-L-histidyl-L-lysine copper
GHK-Cu is the copper(II) complex of GHK, a naturally occurring human tripeptide (glycyl-L-histidyl-L-lysine) found in blood plasma, saliva and urine, whose levels decline with age. It is researched and widely used in cosmetic skincare for skin regeneration, wound healing, collagen support and anti-aging. It is not an FDA-approved drug; it appears in over-the-counter cosmetics and as a research or compounded peptide, with most human evidence coming from small topical-skincare studies.
Also: Tripeptide-3, Ala-His-Lys Copper
AHK-Cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. It is the lesser-known sibling of the naturally occurring GHK-Cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. It is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
- GHK-Cu has stronger research evidence (Human Trials) compared to Copper Peptide AHK-Cu (Limited Research).
Detailed Comparison
| Attribute | GHK-Cu | Copper Peptide AHK-Cu |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | GHK has a strong affinity for copper(II) ions and forms the GHK-Cu complex, which is thought to deliver copper to cells for copper-dependent processes such as connective-tissue formation and antioxidant defense. Its most striking documented activity is broad gene-expression modulation: in cultured human cells, GHK shifts the expression of a large fraction of genes, tending to upregulate tissue-repair genes and downregulate some inflammatory pathways. It stimulates fibroblasts to produce collagen and other extracellular-matrix proteins, supports keratinocyte and blood-vessel activity, and shows antioxidant and anti-inflammatory effects in lab models. Importantly, the copper-binding hypothesis does not fully explain these gene effects, and researchers note the precise mechanism is not yet fully understood. | Copper peptides like AHK-Cu are thought to act as carriers and signals for copper, a metal involved in tissue repair, blood vessel growth and collagen remodeling. In hair, the proposed action centers on dermal papilla cells, the control hub at the base of each follicle that orchestrates the growth cycle. AHK-Cu is hypothesized to keep those cells alive and dividing longer, partly by shifting the balance of survival proteins (more Bcl-2, less Bax) so follicle cells are less likely to enter programmed cell death, which would extend the active growth phase. These are mechanisms observed in cells and isolated follicles, not proven outcomes in people growing hair. |
| Common Dosing | 1-2 mg daily (injection) or 0.05% topical Once daily | Limited community data available See research protocols |
| Administration | Subcutaneous injection or topical application | Topical (scalp serums, solutions) |
| Typical Duration | Varies by application | 3-6 months for visible results |
| Best Time to Take | Evening (for skin/recovery) | Morning or as directed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Much of the mechanistic and efficacy evidence is from cell culture and animal studies. In animals, GHK and GHK-containing dressings improved wound contraction, granulation tissue and collagen deposition in rabbit and rat wounds, and showed protective effects in lung-injury models. In cells, GHK increases collagen, elastin and growth-factor production by fibroblasts and protects keratinocytes from UV damage. Human evidence exists but is limited to small cosmetic trials: facial-cream and eye-cream studies in modest numbers of women (for example a 71-subject facial study and a 41-subject eye-cream study) reported improvements in skin density, thickness and wrinkle appearance. These trials are small and focused on topical skin endpoints, so they do not establish injected or systemic benefits, and there are no large independent randomized trials. Honest summary: strong lab and animal data plus encouraging small topical human studies, but evidence for injected use is preliminary. | The science here is real but narrow. The anchor study is Pyo and colleagues, published in Archives of Pharmacal Research in 2007, which tested AHK-Cu on human hair follicles and dermal papilla cells outside the body. At very low concentrations it significantly lengthened isolated human hair follicles and increased dermal papilla cell proliferation, while reducing apoptosis markers, and notably the effect followed a tight dose-response curve where higher concentrations stopped working. That is genuine peer-reviewed evidence for a biological effect. What does not exist is the part people actually want: randomized controlled human trials showing that applying AHK-Cu to a scalp regrows hair or thickens it in living people. So the honest read is that AHK-Cu has a plausible mechanism and one credible ex vivo and in vitro study behind it, but its real-world hair-growth benefit in humans is unproven, and most consumer claims extrapolate well beyond what that single study supports. |
Frequently Asked Questions: GHK-Cu vs Copper Peptide AHK-Cu
What is the difference between GHK-Cu and Copper Peptide AHK-Cu?
GHK-Cu is a skin & hair peptide that ghk-cu is the copper(ii) complex of ghk, a naturally occurring human tripeptide (glycyl-l-histidyl-l-lysine) found in blood plasma, saliva and urine, whose levels decline with age. it is researched and widely used in cosmetic skincare for skin regeneration, wound healing, collagen support and anti-aging. it is not an fda-approved drug; it appears in over-the-counter cosmetics and as a research or compounded peptide, with most human evidence coming from small topical-skincare studies. Copper Peptide AHK-Cu is a skin & hair peptide that ahk-cu is a synthetic copper-bound tripeptide, alanine-histidine-lysine complexed with a copper ion, engineered mainly for hair and scalp products. it is the lesser-known sibling of the naturally occurring ghk-cu copper peptide, designed in the lab specifically to push hair follicles to keep growing. it is a cosmetic and research ingredient, not an approved hair-loss drug, and its evidence is essentially limited to one notable lab study. The main differences lie in their mechanisms of action and clinical applications.
Which is better, GHK-Cu or Copper Peptide AHK-Cu?
Neither is universally "better" - the choice depends on your specific goals. GHK-Cu is typically used for skin & hair purposes, while Copper Peptide AHK-Cu is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can GHK-Cu and Copper Peptide AHK-Cu be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using GHK-Cu and Copper Peptide AHK-Cu together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.